XM does not provide services to residents of the United States of America.

B. Riley lenders extend deadline for financial report, Bloomberg News reports



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-B. Riley lenders extend deadline for financial report, Bloomberg News reports</title></head><body>

Adds context on B. Riley from paragraph 5 onwards

Aug 28 (Reuters) -B. Riley Financial's RILY.O lenders have granted the company more time to produce an overdue financial report as the investment bank looks for ways to ease its more than $2 billion debt load, Bloomberg News reported on Wednesday.

Bankers put aside requirements for B. Riley to provide financial statements within 45 days after the recent quarter ended, the report said, citing people familiar with the matter.

The additional time is being used to discuss amendments to B. Riley's loan agreements that would give the investment bank more flexibility, according to the report.

B. Riley did not immediately respond to a Reuters request for comment.

The company's stock plunged earlier in the month after it warned of a second-quarter loss in a preliminary report, adding to concerns over its investment in Vitamin Shoppe-owner Franchise Group.

B. Riley had participated in the management-led buyout of Franchise last year. The investment bank's dealings with Franchise's former CEO, Brian Kahn, came under review after Bloomberg News reported that he was a co-conspirator in a securities fraud involving Prophecy Asset Management.

Kahn had denied the allegation, claiming he was unaware of Prophecy's purported investment fraud.

An external investigation and an internal review earlier this year cleared B. Riley of any wrongdoing.

The stock took a further beating after B. Riley said it would not be able to file its quarterly report with the Securities and Exchange Commission by the required date.

Soon after, co-founder and co-CEO Bryant Riley offered to buy the investment bank at a valuation of $212 million. The company had a market value of more than $1 billion at its peak in 2024.

Shares of the company were down 6.4%. The stock has lost nearly 74% so far this year.



Reporting by Pritam Biswas in Bengaluru; Editing by Shounak Dasgupta and Shilpi Majumdar

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.